CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 94 enrolled
Drug / intervention
MusculoSkeletal Ultrasound +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03228342
NCT03228342N/ACompleted
CompareCT.gov

The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)

Clínica de Artritis Temprana·interventional·Posted Jul 24, 2017·Updated Jan 30, 2019

In Brief

A clinical study evaluating MusculoSkeletal Ultrasound for Rheumatoid Arthritis and 2 related conditions. Completed, enrolled 94 participants across 1 site.

Detailed Summary

Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis, Patient Reported Outcomes, Musculoskeletal Ultrasound
CountriesMexico
CollaboratorsInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 24, 2017
Enrollment StartMay 3, 2017
Primary CompletionJan 28, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.9 years ago

Interventions

MusculoSkeletal Ultrasoundother

Patient will be assess with ultrasound (GUS-7 score) and the results will be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.

MusculoSkeletal Ultrasoundother

Patient will be assess with ultrasound (GUS-7 score) and the results will not be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization.